Literature DB >> 17234514

Influence of blood group on mortality and waiting time before heart transplantation in the United kingdom: implications for equity of access.

J C Hussey1, J Parameshwar, N R Banner.   

Abstract

BACKGROUND: We examined waiting time for adult heart transplantation in the UK and sought to determine whether recipients with particular ABO blood groups were disadvantaged.
METHODS: Data were obtained from the National Transplant Database. Registration outcome data were analyzed for 622 new, non-urgent, adult, heart-only registrations from April 1, 1999 to March 31, 2003. Unadjusted waiting times of the 618 first registrations were summarized using Kaplan-Meier estimates.
RESULTS: Death rates were relatively low, with no significant difference in the proportions of patients among the different blood groups who died while waiting. A smaller proportion of blood group O patients were transplanted at 1 year after registration, with a significant difference in waiting time to transplant between blood groups (p < 0.0001). Blood group A and AB patients were generally transplanted sooner than O and B patients, with median waiting times of 81 days (95% CI: 67 to 114) and 76 days (95% CI: 52 to 178) vs 214 days (95% CI: 162 to 308) and 174 days (95% CI: 78 to 249), respectively.
CONCLUSIONS: Although no particular blood group was disadvantaged in terms of mortality on the heart transplant list, blood group O and B patients waited significantly longer for transplantation. The difference was at least partly due to a large proportion of blood group O hearts being used for non-O patients. To address this imbalance, the UK Transplant Cardiothoracic Advisory Group (CTAG) changed the allocation protocol, so that "out-of-zone" offers of blood group O donors for non-urgent patients are now restricted to O and B recipients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234514     DOI: 10.1016/j.healun.2006.10.012

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach.

Authors:  Benjamin A Goldstein; Laine Thomas; Jonathan G Zaroff; John Nguyen; Rebecca Menza; Kiran K Khush
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

2.  Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience.

Authors:  Aditi Nayak; Tiffany Dong; Yi-An Ko; Neile Chesnut; Ann Pekarek; Robert T Cole; Kunal Bhatt; Divya Gupta; Michael A Burke; S Raja Laskar; Tamer Attia; Andrew L Smith; J David Vega; Alanna A Morris
Journal:  Clin Transplant       Date:  2020-02-28       Impact factor: 2.863

3.  Implications of blood group on lung transplantation rates: A propensity-matched registry analysis.

Authors:  Yaron D Barac; Mike S Mulvihill; Morgan L Cox; Muath Bishawi; Jacob Klapper; John Haney; Mani Daneshmand; Matthew G Hartwig
Journal:  J Heart Lung Transplant       Date:  2018-09-25       Impact factor: 10.247

4.  Access to Heart Transplantation: A Proper Analysis of the Competing Risks of Death and Transplantation Is Required to Optimize Graft Allocation.

Authors:  Christelle Cantrelle; Camille Legeai; Aurélien Latouche; Philippe Tuppin; Carine Jasseron; Laurent Sebbag; Olivier Bastien; Richard Dorent
Journal:  Transplant Direct       Date:  2017-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.